Home as the new frontier for the treatment of COVID-19: the case for anti-inflammatory agents - The Lancet Infectious Diseases
Viral kinetics of SARS-CoV-2 following onset of COVID-19 in symptomatic patients infected with the ancestral strain and omicron BA.2 in Hong Kong: a retrospective observational study - The Lancet Microbe
What to Know About EG.5 (Eris)—the Latest Coronavirus Strain > News > Yale Medicine
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry - The Lancet Oncology
COVID-19 Incidence and Death Rates Among Unvaccinated and Fully Vaccinated Adults with and Without Booster Doses During Periods of Delta and Omicron Variant Emergence — 25 U.S. Jurisdictions, April 4–December 25, 2021 | MMWR
Past infections may shape your COVID booster's punch against Omicron
Effectiveness of previous infection-induced and vaccine-induced protection against hospitalisation due to omicron BA subvariants in older adults: a test-negative, case-control study in Quebec, Canada - The Lancet Healthy Longevity
TaqPath COVID-19 Tests Support Detection of SARS-CoV-2 in Samples Containing the Omicron Variant - Clinical Conversations
SARS-CoV-2 Omicron variant found to display increased resilience to antiviral type I interferon response
Understanding BA.2's rise across the U.S. and Oregon : Oregon Health News Blog
Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study - The Lancet Infectious Diseases
Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2 - The Lancet
Understanding Omicron, the new COVID-19 variant of concern | COVID | UT Southwestern Medical Center
Effects of COVID-19 vaccination and previous SARS-CoV-2 infection on omicron infection and severe outcomes in children under 12 years of age in the USA: an observational cohort study - The Lancet Infectious
Study identifies current mechanism of action behind reduced severity of Omicron variant COVID-19 infection
Vaccine-Induced Immune Response to Omicron Wanes Substantially Over Time | National Institutes of Health (NIH)
Information for Persons Who Are Immunocompromised Regarding Prevention and Treatment of SARS-CoV-2 Infection in the Context of Currently Circulating Omicron Sublineages — United States, January 2023 | MMWR
Why Breakthrough COVID? Antibodies Fighting Original Virus May Be Weaker Against Omicron
Associations of COVID-19 symptoms with omicron subvariants BA.2 and BA.5, host status, and clinical outcomes in Japan: a registry-based observational study - The Lancet Infectious Diseases
COVID-19 vaccine effectiveness against the omicron (BA.2) variant in England - The Lancet Infectious Diseases
Georgia State Study Finds COVID-19 Omicron Variant Leads to Less Severe Disease in Mice - Georgia State University News - College of Arts and Sciences, Coronavirus Research, Press Releases, Research, University Research -
What makes omicron spread so quickly? A new study offers a tantalizing clue : Goats and Soda : NPR
Researchers unravel omicron's secrets to better understand COVID-19 – Washington University School of Medicine in St. Louis
Frontiers | Drugs for the prevention and treatment of COVID-19 and its complications: An update on what we learned in the past 2 years
New data offer glimpse at impact of emerging COVID variants
